Financial statements Pharmag
Cash flow statement of Pharmag
Company age:
Age:
24 y. 28 d.
Share capital:
Share capital:
5 891 000 PLN
Cash inflows of PHARMAG
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 1 404 443,12 | 1 274 977,23 | 1 086 437,97 | 198 681,56 | 996 937,45 | -1 488 460,92 |
| Net cash flow from investing activities | -283 156,82 | -195 303,03 | -270 118,03 | -209 956,98 | -546 888,31 | -606 205,45 |
| Net cash flow from financial activities | -985 781,59 | -1 031 848,03 | -948 345,05 | 38 919,29 | -526 568,11 | 2 208 582,93 |
| Total net cash flow | 132 504,71 | 47 826,17 | -132 025,11 | 27 643,87 | -76 518,97 | 113 916,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.